Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.

Cite this paper

@article{Vrachimis2015NotAD, title={Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.}, author={Alexis Vrachimis and Christian Wenning and Joachim Ger\ss and Henning Dralle and Mohammad Vaez Tabassi and Otmar Schober and Burkhard Riemann}, journal={Journal of surgical oncology}, year={2015}, volume={112 1}, pages={9-14} }